Novavax Medical Information
DISCLAIMER: THIS PAGE IS INTENDED FOR HEALTHCARE PROFESSIONALS IN Austria ONLY.
If you are NOT a Healthcare Professional in Austria, please switch to the Consumer Medical Information page.
Information on the NuvaxovidTM XBB.1.5▼ dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601)
If your enquiry is regarding the NuvaxovidTM XBB.1.5▼ dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601), you can find some useful information in the resources below.
Request Medical Information
Healthcare Professionals may request medical information via ONE of the following ways:
Option 1: Complete and submit a Medical Information Request Form by clicking on the button below.
Option 2: Call +43 0720 881304 between 09:00-17:00.
Report an Adverse Event (AE)
If you are concerned about an adverse event, it should be reported to the Federal Ministry of Social Affairs, Health Care and Consumer Protection, Bundesamt für Sicherheit im Gesundheitswesen (BASG) at http://www.basg.gv.at.
Alternatively, adverse events of serious concern in association with a Novavax product can be reported to Novavax Pharmacovigilance at +43 0720 881304 or via the Novavax Adverse Event Reporting Form.
Report a Product Quality Complaint
If you have a product quality complaint related to a physical issue with a Novavax product or its packaging, please call +43 0720 881304 between 09:00-17:00.